Dr. Michael Mazowiecki, MD

NPI: 1841304581
Total Payments
$560,146
2024 Payments
$46,587
Companies
32
Transactions
995
Medicare Patients
1,288
Medicare Billing
$185,963

Payment Breakdown by Category

Other$464,046 (82.8%)
Consulting$42,598 (7.6%)
Food & Beverage$30,878 (5.5%)
Travel$22,562 (4.0%)
Education$61.10 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $464,046 232 82.8%
Consulting Fee $42,598 20 7.6%
Food and Beverage $30,878 629 5.5%
Travel and Lodging $22,562 111 4.0%
Education $61.10 3 0.0%

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $115,571 123 $0 (2024)
EMD Serono, Inc. $76,734 132 $0 (2024)
ABBVIE INC. $56,505 154 $0 (2024)
Acorda Therapeutics, Inc $55,190 58 $0 (2022)
GENZYME CORPORATION $46,032 79 $0 (2024)
Genentech USA, Inc. $44,934 58 $0 (2021)
Biohaven Pharmaceuticals, Inc. $44,713 45 $0 (2021)
Biohaven Pharmaceutical Holding Company Ltd. $38,481 39 $0 (2022)
E.R. Squibb & Sons, L.L.C. $37,505 45 $0 (2024)
Allergan, Inc. $9,981 25 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $46,587 106 ABBVIE INC. ($26,298)
2023 $78,251 146 ABBVIE INC. ($29,644)
2022 $111,193 198 Biohaven Pharmaceutical Holding Company Ltd. ($38,481)
2021 $89,174 148 Biohaven Pharmaceuticals, Inc. ($43,588)
2020 $68,568 85 Acorda Therapeutics, Inc ($27,615)
2019 $96,219 150 Genentech USA, Inc. ($25,887)
2018 $61,178 113 Biogen, Inc. ($37,643)
2017 $8,975 49 EMD Serono, Inc. ($7,618)

All Payment Transactions

995 individual payment records from CMS Open Payments — Page 1 of 40

Date Company Product Nature Form Amount Type
12/30/2024 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Travel and Lodging Cash or cash equivalent $212.20 General
Category: Neuroscience
12/27/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $18.42 General
Category: NEUROSCIENCE
12/20/2024 Celgene Corporation ZEPOSIA (Drug) Consulting Fee Cash or cash equivalent $2,400.00 General
Category: Neuroscience
12/20/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $12.30 General
Category: NEUROSCIENCE
12/09/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $45.19 General
12/06/2024 Celgene Corporation ZEPOSIA (Drug) Travel and Lodging Cash or cash equivalent $536.32 General
Category: Neuroscience
12/06/2024 Celgene Corporation ZEPOSIA (Drug) Travel and Lodging Cash or cash equivalent $212.19 General
Category: Neuroscience
12/06/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $124.99 General
Category: Neuroscience
12/06/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $50.12 General
Category: Neuroscience
12/06/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $50.12 General
Category: Neuroscience
12/06/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $31.39 General
Category: Neuroscience
12/06/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $26.54 General
Category: Neuroscience
12/06/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $26.54 General
Category: Neuroscience
12/04/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Consulting Fee Cash or cash equivalent $500.00 General
Category: Immunology
11/21/2024 GENZYME CORPORATION Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,906.00 General
11/21/2024 GENZYME CORPORATION Food and Beverage In-kind items and services $121.36 General
11/15/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $8.75 General
Category: Neuroscience
10/30/2024 UCB, Inc. Food and Beverage In-kind items and services $128.51 General
10/11/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $7.93 General
Category: Neuroscience
10/08/2024 ABBVIE INC. QULIPTA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,625.00 General
Category: NEUROSCIENCE
10/02/2024 UCB, Inc. Zilbrysq (Biological) Consulting Fee Cash or cash equivalent $1,140.00 General
Category: Neurology
09/26/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $8.12 General
Category: NEUROSCIENCE
09/19/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $104.99 General
Category: NEUROLOGY
09/19/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $20.00 General
Category: NEUROLOGY
09/18/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $8.96 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 368 479 $112,842 $57,627
2022 4 327 434 $100,418 $51,856
2021 5 330 427 $95,235 $50,277
2020 5 263 279 $52,806 $26,203
Total Patients
1,288
Total Services
1,619
Medicare Billing
$185,963
Procedure Codes
19

All Medicare Procedures & Services

19 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 202 308 $68,530 $37,932 55.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 96 96 $30,403 $14,167 46.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 28 $4,638 $2,286 49.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 19 19 $4,762 $2,065 43.4%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2023 25 28 $4,508 $1,177 26.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 185 287 $63,858 $36,481 57.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 82 82 $25,969 $11,960 46.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 27 $4,473 $1,818 40.7%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2022 35 38 $6,118 $1,597 26.1%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 114 190 $42,895 $25,331 59.1%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 78 78 $24,952 $12,391 49.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 82 102 $16,635 $8,475 50.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 26 26 $6,412 $2,676 41.7%
95816 Measurement and recording of brain wave (eeg) activity, awake and drowsy Facility 2021 30 31 $4,342 $1,404 32.3%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 71 84 $16,539 $7,980 48.3%
99358 Prolonged patient service without direct patient contact first hour Office 2020 69 69 $11,648 $5,969 51.2%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 34 34 $9,238 $5,242 56.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 67 70 $10,871 $4,414 40.6%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 22 22 $4,510 $2,597 57.6%

About Dr. Michael Mazowiecki, MD

Dr. Michael Mazowiecki, MD is a Neurology healthcare provider based in Greensburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841304581.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mazowiecki, MD has received a total of $560,146 in payments from pharmaceutical and medical device companies, with $46,587 received in 2024. These payments were reported across 995 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($464,046).

As a Medicare-enrolled provider, Mazowiecki has provided services to 1,288 Medicare beneficiaries, totaling 1,619 services with total Medicare billing of $185,963. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Greensburg, PA
  • Active Since 08/19/2006
  • Last Updated 01/26/2017
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1841304581

Products in Payments

  • NURTEC ODT (Drug) $83,359
  • QULIPTA (Drug) $55,702
  • INBRIJA (Drug) $54,883
  • OCREVUS (Biological) $44,829
  • TYSABRI (Biological) $43,702
  • ZEPOSIA (Drug) $37,545
  • VUMERITY (Drug) $33,145
  • Mavenclad (Drug) $30,398
  • TECFIDERA (Drug) $27,288
  • LEMTRADA (Drug) $20,856
  • MAVENCLAD (Drug) $15,877
  • Mavenclad (Biological) $11,637
  • UBRELVY (Drug) $10,624
  • EMGALITY (Drug) $8,118
  • Rebif (Biological) $7,624
  • WAKIX (Drug) $5,417
  • Ponvory (Drug) $5,185
  • DISEASE STATE (Drug) $2,352
  • AUBAGIO (Drug) $1,898
  • VNS Therapy (Device) $1,346

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Greensburg